GIBLIB

Healthcare Dive | July 15, 2020

Digital health received $6.3 billion in funding in the first half of 2020, shattering all previous funding records, according to a new report from research firm Mercom Capital Group. The amount is a 24% increase from the first half of 2019.Telehealth, perhaps unsurprisingly, received the most money as the COVID-19 pandemic drove unprecedented virtual care adoption, with $1.7 billion in funds.However, the pace of funding slowed in the second quarter with $2.8 billion across 161 deals,...

Health Technology

Northwell Health | April 13, 2022

Northwell Health, New York’s largest healthcare provider, and Aegis Ventures, a New York-based startup studio announced at their inaugural Healthcare AI Innovation Summit the finalization of definitive agreements to launch Ascertain, a joint company creation platform. Ascertain is a first-of-its-kind partnership that pairs a dynamic venture studio with one of the nation’s largest and most impactful health systems to develop and commercialize breakthrough healthcare AI companies th...

Health Technology

Healthcare Triangle | March 30, 2021

Healthcare Triangle is pleased to declare its dispatch of readabl.ai, a condition of-craftsmanship, progressed programmed catch arrangement fueled by Artificial intelligence (AI) and Natural Language Processing (NLP) for archive characterization, data extraction and steering. It is explicitly intended for healthcare associations - to assist them with robotizing their record driven cycles. Read More

Agadia | July 16, 2020

Agadia, a healthcare management technology company widely known for innovations in Utilization Management software, has announced the expansion of their suite of solutions to include FormularyHub, an RxContinuum SolutionTM, a fully customizable, web-based tool for Formulary Benefit Management.With the introduction of FormularyHub, the Managed Care market can now leverage an effective and condensed platform to control all attributes of a Formulary, with the ability to build, configure, and ...